West Coast Financial LLC Reduces Position in Encompass Health Co. (NYSE:EHC)

West Coast Financial LLC decreased its stake in shares of Encompass Health Co. (NYSE:EHC) by 2.4% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 47,407 shares of the company’s stock after selling 1,181 shares during the quarter. West Coast Financial LLC’s holdings in Encompass Health were worth $4,801,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Charles Schwab Investment Management Inc. lifted its holdings in Encompass Health by 0.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 644,764 shares of the company’s stock valued at $59,544,000 after buying an additional 4,345 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S bought a new stake in Encompass Health during the 4th quarter valued at about $4,160,000. US Bancorp DE lifted its holdings in Encompass Health by 9.6% during the 4th quarter. US Bancorp DE now owns 1,380 shares of the company’s stock valued at $127,000 after buying an additional 121 shares in the last quarter. Farallon Capital Management LLC lifted its holdings in Encompass Health by 15,266.7% during the 4th quarter. Farallon Capital Management LLC now owns 461,000 shares of the company’s stock valued at $42,573,000 after buying an additional 458,000 shares in the last quarter. Finally, New York State Teachers Retirement System lifted its holdings in Encompass Health by 0.3% during the 4th quarter. New York State Teachers Retirement System now owns 76,102 shares of the company’s stock valued at $7,028,000 after buying an additional 200 shares in the last quarter. Institutional investors own 97.25% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on EHC. Barclays lifted their price objective on shares of Encompass Health from $118.00 to $129.00 and gave the company an “overweight” rating in a report on Friday, April 25th. KeyCorp boosted their price target on shares of Encompass Health from $122.00 to $135.00 and gave the company an “overweight” rating in a report on Tuesday, May 27th. Truist Financial restated a “buy” rating and issued a $135.00 price target (up previously from $116.00) on shares of Encompass Health in a report on Monday, April 28th. Wall Street Zen upgraded shares of Encompass Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 24th. Finally, William Blair restated an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Eight equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $127.00.

Insider Buying and Selling

In other Encompass Health news, insider Elissa Joy Charbonneau sold 4,279 shares of the business’s stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $116.61, for a total transaction of $498,974.19. Following the sale, the insider now owns 11,958 shares of the company’s stock, valued at approximately $1,394,422.38. The trade was a 26.35% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP John Patrick Darby sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total transaction of $1,147,900.00. Following the sale, the executive vice president now directly owns 79,710 shares in the company, valued at approximately $9,149,910.90. This represents a 11.15% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 132,663 shares of company stock worth $16,034,082 in the last 90 days. 2.10% of the stock is owned by corporate insiders.

Encompass Health Trading Down 0.0%

NYSE EHC opened at $121.22 on Friday. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84. The firm has a market cap of $12.22 billion, a PE ratio of 27.18, a price-to-earnings-growth ratio of 2.31 and a beta of 0.89. The company has a 50 day moving average price of $111.55 and a 200 day moving average price of $102.58. Encompass Health Co. has a 52 week low of $82.74 and a 52 week high of $123.13.

Encompass Health (NYSE:EHC) last posted its quarterly earnings data on Thursday, April 24th. The company reported $1.37 EPS for the quarter, topping the consensus estimate of $1.19 by $0.18. The firm had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Encompass Health’s revenue was up 10.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.12 EPS. As a group, sell-side analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 annualized dividend and a dividend yield of 0.56%. Encompass Health’s dividend payout ratio (DPR) is presently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.